All news from Venereology
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity.
A new study suggests that use of HIV RNA expression inhibitors as adjunct therapy might diminish atypical inflammation and restore immune function in HIV-infected individuals on combination antiretroviral therapy (cART). These findings appear online in the journal Nature Communications.
What if the bacteria that live in your gut could monitor your health, report disease, and produce beneficial molecules? Researchers have gotten one step closer to creating such a 'synthetic microbiome' by engineering different species of bacteria so they can talk to each other. Given that there are over 1,000 different strains of intestinal interlopers in the human gut, such coordination is crucial for the development of systems that can sense and improve human digestive health.
A new study examines that artificial intelligence (AI) is better at predicting the risk of death in patients with heart disease than models designed by medical experts. The study was published in PLOS One, adds to the growing evidence that AI could revolutionize healthcare in the UK and beyond. So far, the emphasis has been on the potential of AI to help diagnose and treat various diseases, but these new findings suggest it could also help predict the likelihood of patients dying too.
A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. In a study published by the journal Neurology, researchers at Sahlgrenska Academy, Sweden, has identified a superior blood-based biomarker for assessing subtle brain injury.
A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform, to treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalised medicine.
TB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether a new four-drug regimen can treat most types of tuberculosis (TB) including multidrug-resistant TB (MDR-TB) more quickly and effectively than currently-available treatments.
The first patients have been enrolled at the National Center for Tuberculosis and Lung Disease in Tbilisi, Georgia. SimpliciTB is expected to enroll 450 people with TB, including up to 150 with MDR-TB across at least 26 centers in 10 countries in Africa, Asia, Europe and Latin America.
Southern Africa has some of the highest rates of sexual assault in the world, with 20% of adolescent girls and boys reporting that they have been forced to have sex. In many cases, they are also the perpetrators: In one survey, 12% of boys and 5% of girls admitted they have forced someone else onto sex.
High fever. Cough. Runny nose. Red, watery eyes. It may not be the flu. It could be measles. Measles cases are on the rise in Europe, with more than 40,000 cases and 37 deaths in the first six months of 2018. In the United States, the Centers for Disease Control and Prevention (CDC) reported that they've identified 124 measles cases in 22 states and the District of Columbia this year through August.
